Replies to post #157848 on Vivos Inc (RDGL)

[SC8]

Meetings are done? Commenter quoting RDGL Linkedin response is clear as day: "Meeting after the animal studies are completed."

So RDGL is expecting FDA review comments in April rather than a 4th meeting. Then when ever containment results are submitted, RDGL will request a 4th meeting. That means submission of both phase 1 containment and phase 2 efficacy results before 4th meeting request.

Long ways to go before path to IDE submission is clear, aka a forecast timetable is possible. Just hoping today's update enough to get atm pss up before offering.